top of page



A New Milestone in Prader-Willi Syndrome Care: FDA Approves VYKATâ„¢ XR (DCCR) for Hyperphagia
Prader-Willi syndrome (PWS) is a rare genetic disorder that disrupts multiple aspects of life, from an insatiable appetite (hyperphagia)...
7 hours ago2 min read
0 comments


Advancing Treatments for Prader-Willi Syndrome: Key Insights from the Miller 2025 Review
An overview of a recent review by Miller et al. (2025) exploring current and emerging therapies for Prader-Willi Syndrome (PWS)
Mar 102 min read
0 comments


Raising Awareness for PWS Awareness Month: Join the Effort!
May is PWS Awareness Month, a time dedicated to increasing understanding of PWS and supporting the quest for treatments and a cure.
May 16, 20242 min read
0 comments

Embracing Hope: Rare Disease Day 2024 and ConSynance Therapeutics' Commitment
On this Rare Disease Day, we stand in solidarity with the rare disease community to shine a light on conditions that often go unnoticed.
Feb 28, 20242 min read
0 comments
bottom of page